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THE SULPFIANILAMIDES IN GONORRHOEA 
Introduction. 
It is difficult to realise that in four years 
the treatment of gonorrhoea has been revolutionised 
by the introduction of the sulphanilamides. Pre- 
vious to this the results obtained were by no means 
good even in expert hands, despite an Act of Par- 
liament being passed which prohibited treatment 
except by qualified practitioners. Complications 
were many, and certain cure by no means universal. 
But in 1936 Professor Domagk claimed to have dis- 
covered a substance, a dark red dye, which had a 
specific action against streptococci, and which he 
called Prontosil. Further investigations confirmed 
his findings. This was a notable discovery. It is 
true that even in the 17th century quinine was known 
to be effective in malaria, and from early days 
mercury was used in syphilis. In 1910 Ehrlich and 
ata had discovered a synthetic organic arsenical, 
Arsphenamine, later Neoarsphenamine, and had proved 
its clinical value in spirochaetal infections. 
Thus, though it had been recognised that protozoal 
infections could be treated by chemotherapy, bac- 
terial diseases were still thought to be resistant 
to this type of therapy, and any drug which would 
kill/ 
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kill bacteria was thought to be too toxic for the 
host. 
Subsequent to the discovery of Prontosil, 
chemists in all countries have attempted to improve 
on it, and we in this country have used sulphanila- 
mide, sulphapyridine, and now sulphathiazole. 
Venereologists soon realised that here they had a 
drug which could be taken by the mouth for the cure 
of gonorrhoea, and this has opened up a tremendous 
field for investigation which is still going on. 
There is much to be done to find the correct dosage 
and time to give it, and how to avoid toxic effects, 
and many other points are still under review. 
The figures published by the Chief Medical 
Officer of the Ministry of Health show that in 1938 
there were 41,759 cases being treated in treatment 
centres in England and J'ales, and in 1937, 43,802, 
of which 29,250 were new cases and over 27,000 of 
less than one year's duration. Of these, 21% of 
males were defaulters, i.e. not having been dis- 
charged as cured or not having completed treatment. 
The fall of over 2,000 is no doubt due to the sul- 
phanilamides. when it is realised what a toll is 
taken on the health of the community by gonorrhoea 
alone, it is apparent that if we have a drug of the 
sulphanilamide group which will cure early and cer- 
tainly, we are making a great advance. It is of 
even/ 
even greater importance in these days when the whole 
country is working at top pressure if a man can be 
cured early, and without delaying complication go 
back to his working bench in the minimum period of 
time. Even now the Minister of Health reports an 
increase of 1520 in venereal disease which is almost 
always the case in time of war. 
If we consider also the Armed Forces and look 
at the following tables for 1937, we realise how 
gonorrhoea affects their efficiency, especially now 
when we are calling up so many men. Every man who 
is found to be suffering from gonorrhoea has to go 
to a special hospital for two weeks and remain under 
observation for three months, and if the sulphanila- 
mides can shorten this time they will be of extra- 
ordinary value. 
Table 1 
Admission to Hospital per 1,00C for 1937 for acute 
gonorrhoea in the Ro-al Navy Home and Abroad. 
Stations Average Strength Acute Gonorrhoea 
Home 34,160 17.97 
Home Fleet 14,735 21.85 
Mediterranean 22,700 32.11 
N.American ..Indies 2,245 81.06 
China 8,190 114.16 
East Indies 3,260 28.83 
Africa 1,110 92.88 
1 
Table 2 
Royal Air Force. 
Stations Average Strength Gonorrhoea 
Home 35,823 4.1 
Abroad 12,011 12.1 
Table 3 
The. Army. 
Stations Average Strength Gonorrhoea 
Home 89,605 8.2 
India 59,059 25.7 
Aden 380 15.8 
]3ermada 437 36.3 
Ceylon 273 84.2 
North China - - 
South China 5,960 105.0 
Shanghai - 
Egypt 15,840 24.5 
Gibraltar 2,006 16.5 
Jamaica 539 61.2 
Malaya 3,270 37.0 
Malta 4,131 11.9 
Mauritius 115 113.0 
In the present thesis the author proposes to 
describe the results of treatment by the sulphanila- 
mides in a series of 180 cases. These cases were 
treated 
treated at the Venereal Diseases Clinic of the 
Cumberland County Council and Corporation of 
Carlisle at the Cumberland Infirmary. Patients 
were drawn from Carlisle, Cumberland, adjacent 
parts of Scotland, and 'Westmorland. 
Chemistry and Pharmacology of the Sulphanilamides 
From a chemical point of view the compounds of 
sulphanilamide are divided into two classes, the 
first where there is a substitution of the amino 
group, and the second where there is a substitution 





(Class 1 substituents) 
Amide group 
(Class 2 substituents) 
In the first class (fig. 1) we have the origi- 
nal Prontosil which is now used more on the Conti- 
nent. Chemists working not only in this country 
hut in France and America have shown that this com- 
pound owed its activity to reducing in the body to 
active sulphanilamide and inactive triamenobenzene. 
Figuré 2 
Compounds of Sulphanilamide. 
Proseptasine Prontosil 
NPICH2 K-----I> 
S O2Nh2 ` S02NH2 
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Compounds in the second class (fig. 3) do not 
split up into sulphanilamide in the body. The two 
substances of this body which have been used are 
Uleron and II & B 693. 
Figure 3 
Compounds of Sulphanilamide. 
Class 2 (substituents of amide group) 
Uleron 
NH 
M B 693 
VH2 
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The two compounds now most widely used in gon- 
orrhoea are M . B 693 and Uleron, the former in this 
country and the latter abroad, especially in 
Germany. As regards Uleron, since 1937 it has been 
estimated that over half a million cases of gonorr- 
hoea have been treated in various parts of the 
world. Its danger, however, is that in clinical 
practice if large doses are employed they sometimes 
cause peripheral neuritis, a condition which sul- 
phanilamide itself does not produce. German 
clinicians/ 
clinicians have stated that they avoid this by mak- 
ing use of what they term " stoss" therapy, i.e. the 
application of short bouts lasting for three or 
four days and separated by intervals of a week. 
They do not give more than three "stosses ", each 
one not exceeding fifteen grammes. The daily amount 
may be given as 3 grammes for 4 days or 4 grammes 
for 3 days. A special group of cases, 6,000 in all 
subject to standard tests for cure they say should 
result in 60 -70% being cured after one "stoss ", 
$0 -85% after the second, and of the remaining 
15-20%, 6 -8% (of the total cases) should respond to 
a third " stoss," Some workers state that they get 
better results if they start treatment after four- 
teen days following the first manifestation of the 
disease when the patient is producing his own im- 
munity against the gonococcus. 
Hamilton WYilkie1had 100 acute and 20 chronic 
cases and showed an average clinical success of 
2 
75% of cure. D. F. Walsh had 26 cases with only 1 
toxic result - an urticarial rash and sickness - 
but failed to get a clinical cure in 11 cases. 
B 693 is now used to a great extent in 
this country and it is generally agreed that in the 
treatment of gonorrhoea in the male it is much more 
therapeutically potent than any of its rivals. 
II & B 693 exercises its curative action at a very 
early/ 
early stage in the disease. The urethral discharge 
disappears sometimes in twenty -four hours, and well 
within a week pus cells no longer appear in the 
urine. Unlike other sulphanilamides it is not de- 
pendent for its maximum_ effects upon the develop- 
ment of specific immunity, as as a rule in cases 
adequately treated in their early stages the Com- 
plement Fixation test never becomes positive. There 
are, however, two important points which must be 
remembered with this successful drug. First, when 
we give it we stop the discharge in its early stages 
and we are tempted to reduce the number and variety 
of our tests and reriod of observation for cure, 
and many Authorities remark on the increase in the 
number of defaulters, as men and women when they 
secure relief from their acute symptoms and signs 
do not return to subject themselves to tests for 
cure and may be still infectious. Other Authori- 
3 
ties speak of relapses, especially A. J. CokkinS1 
(St. Mary's Hospital), who has seen a genuine re- 
lapse as long as eight months after complete early 
cure, and had also a number of six month relapses 
as well as three and four month relapses. Secondly, 
all Authorities agree that M & B 693 must be given 
in large doses from the very start to have its full 
effect. General practitioners are apt to begin 
with .5 gm. t.i.d. and are disappointed with their 
results./ 
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results. ;Then these patients are sent to the 
clinic it is found that it is no use starting in- 
tensive treatment for at least two weeks after the 
last dose, as the gonococcus seems to have acquired 
a resistance to the drug, or the capacity of the 
liver is such that it can detoxicate a larger pro- 
portion of the compound when it is present in the 
blood in small amounts. Also, these small amounts 
as much as .5 gm. t.i.d. - for weeks on end may be 
definitely toxic without getting the required 
result. 
Since 1938 when May & Baker introduced M & B 
693 there have been numerous articles written in 
this country and in America and all Authorities do 
not yet agree on the most suitable dose or method 
4 
of using it. F. J. T. Bowie treated 31 patients - 
30 male and 1 female - of which 23 were suffering 
from acute urethritis. He gave 3 grammes daily for 4 .o 
7 days, then 1.5 grammes for another 7 days, com- 
bined with urethral irrigation with potassium per- 
manganate, 1/8,000. His results were, 6 cases 
gonococcus negative in 1 day, 10 in 2 days, 6 in 3 
days, 1 in 8 days, and 1 patient did not become 
negative for 17 days, but there was reason to sup - 
pose he was not taking his tablets regularly. 
5 
Batchelor, Lees, and Thompson give a most 
interesting paper. They found M & B 693 greatly 
superior/ 
superior to any other drug they had used, as it 
produced a more rapid curative effect, toxic effects 
were less severe, drug resistance was much less com- 
mon, and the complications were low. In males with 
b 
acute ure thri ti s they give for 2 days $ grammes a 
day, 2 days grammes, 4 days grammes, and for G 
final days 3i, grammes. Out of 445 cases 209 (47;) 
were cured, but 236 (53 %) proved to be defaulters, 
which shows that those who completed treatment had 
100% cure. Batchelor, Lees, and Thompson rightly 
point out that the large numbers who default in the 
first two weeks present a menace to the success of 
the sulphanilamides. In all their cases they dis- 
pensed with irrigation in any form. 
6 
MacKinnon brings out the point that the ob- 
ject of treatment of gonorrhoea is to attain cure 
as quickly as )ossible, and he shows to what extent 
this has been achieved by M & B 693. In 3,454 men 
treated by irrigation it took on the average 7.44 
weeks to attain cure; with tleron 5.28 weeks, and 
with M & 13 693, 3.71 weeks. All these cases were 
treated by irrigation, 1/8,000 potassium perman- 
ganate. MacKinnon thinks irrigation important as 
in his opinion the sulphanilamides seem only to 
attack the extracellular gonococci and the intra- 
cellular are protected, and he attributes the re- 
lapsed case which at first is apparently cured to 
having/ 
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having been re- infected by its own intracellular 
gonococci lying in urethral crypts which can be 
at by irrigation alone. 
Albucid, a modification of sulphanilamide pro- 
duced by the firm of Schering, has also been tried 
in this country. It is supposed to be less toxic, 
even in large doses, but as a cure for gonococci it 
is much weaker. The makers suggest for treatment: - 
1st day 15 tablets; 2nd day 12 tablets; 3rd day 9 
tablets; 4th day 6 tablets - in all 21 grammes - 
and they advise delayed chemotherapy. 
5 
Batchelor, Lees, and Thompson tried it with 
13 cases and report 4 successes and 9 failures. It 
would seem, therefore, to be a drug to be used only 
in those cases where patients cannot tolerate M & B 
693 which is too toxic for them. 
ProseïDtasine, the first sulphanilamide to be 
produced in this country by May & Baker in 1936, 
has certainly now been superseded by M & B 693e 
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Historiy of t?.le Sulphanilamides 
Ever since Ehrlich's discovery of Salvarsan, 
new remedies for protozoal diseases have appeared 
at regular intervals. The results have been so en- 
couraging that it was felt it was only a matter of 
time before a specific drug would be discovered for 
each disease, but in bacterial infections the out- 
look has been more gloomy and not much success was 
expected from chemotherapy. However, in 1935 
Professor Domagk claimed to have discovered a sub- 
stance with a specific action against streptococci. 
This substance, a dark red dye, was called Pronto - 
sil. The discovery of this substance, however, 
8 
really goes to the credit of a chemist Gelmo who, 
working on the chemistry of dyes in 1908, was the 
first to mention para amino benzene sulphonamide, 
but no chemical or clinical trials were made with 
this compound. In 1911 
9 
Sisley and Porcher showed 
that chrysordine diamino 
azo benzol breaks down in the intestine because of 
bacterial action, and splits at the double bond. 
H2Tt02S 
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10 
In 1913 Eisenberg discovered the bacterial 
power of certain azo dyes, and used them in the 
treatment of trypanosomiasis. 
In 1914 scarlet red medicinal toluyl azo tol- 
uyl azo beta naphthol was accepted by the Council 
on Pharmacy and Chemistry of the American Medical 
11 
Association, and was used in the treatment of 
ulcers to stimulate growth of epithelial cells. 
12 
In 1926, Ostromyolensky introduced Pyridium into 
therapeutics for use in infections of the urinary 
.13 
tract. In 1932 Meitzsch and Klarer synthesised 
an azo dye for the dye industry _and. obtained a 
patent. This compound has become known as Pronto - 
sil rubrurn. It is a sulphonamide 2' : 4' diamino 
azo benzene, a red crystalline powder. 
H2NO2b N It 
NH2 
This led to Domagk discovering its action in strep- 
tococcal infection in mice, and so to Domagk right- 
fully belongs the credit for the discovery of Pron- 
tosil as a chemotherapeutic agent in bacterial 
infection. It was confirmed in this country by 
workers attached to queen Charlotte's Hospital, 
14 
London, and a paper appeared in the Lancet 
(June 6, 1936) showing its remarkable curative ef- 














Later this Prontosil red was simplified to Pronto- 
sil album, and an explanation of its action was put 
15 
Í 
forward by Colebrook, Buttle, and O'Meara who 
showed that apparently Prontosil itself was reduced 
to sulphanilamide in the body and acted in the 
16 
bloodstream. In 1937 H. Proom found that Prontosil 
album not only attacked the streptococci, but sug- 
gested that it might be of use in cerebro- spinal 
fever attacking the meningococcus. This has since 
been proved in the treatment of cerebro- spinal 
meningitis with M & B 693. In 1936 the firm of 
May & Baker produced a sulphanilamide called 
Proseptasine, and in 1939 M B 693 - Dagenan, as 
it is now called. 
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The Absorption, Excretion and Toxicity of 
3uiphanilamides. 
The pharmacology of sulphanilamides has been 
studied by Marshall and his co- workers in America. 
17,18,19,20,21,22,23. 
They proved that sulphanila- 
mide is absorbed from the small intestine and not 
from the stomach. After taking the drug by mouth 
the concentration in the blood rises rapidly, 
reaching a maximum in about three hours and falling 
to zero in about twenty -four hours.. It finds its 
way into the secretions of the body and all the 
tissues except bone and fat. It is excreted in the 
urine partly as the free base and partly in the 
acetylated inactive form. It is of interest that 
the rate of elimination is independent of the plas 
ma level but follows the urine flow. It would seem 
that 70-80% of the drug is re- absorbed into the 
kidney tubules after filtration through the glomer- 
uli, this making it possible to wash the drug from 
the system by diuresis in case of overdosage or 
any toxic symptoms. The marked antigonococcal 
action of the sulphanilamides does not depend upon 
the sulphanilamides in the urine. Vest, Hill, 
Harrill, and Pitts in 3altimore showed in several 
of their cases of gonococcal urethritis that if the 
volume of fluid ingested was so restricted that no 
urine/ 
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urine was excreted during the first twelve hours of 
treatment, it made no difference as both discharge 
and gonococci were found to disappear just as 
rapidly in those cases where urinary secretion was 
normal. 
M & B 693 is absorbed more slowly than sulph- 
anilamide. It is excreted in the urine, partly as 
the free base and partly as the acetyl derivative. 
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Bacteriostatic Action of Sulphanilamide 
The latest theory as to the bacteriostatic 
action of the sulphanilamide is put forward by 
Woods, Fildes, and Lockwood and Lynch, and com- 
mented upon by Bracey and Harper of Liverpool in a 
letter in the Lancet. In short, their theory is 
that p- aminobenzoic acid and peptone act as inhibi- 
tors of the bacteriostatic action of sulphanilamide. 
They point out that the bacterial cell, in common 
with other living organisms, if it is to be kept 
alive must carry out various metabolic activities 
which require the presence of certain enzymic 
systems, varying with the type of bacteria. Now, 
animal and plant enzymes are susceptible to the 
action of certain poisons - e.g. cyanides and 
urethanes - which inhibit their activity. The sug- 
gestion is that the same applies to the sulphanil- 
amides and that the enzymic system affected by them 
is that concerned with the metabolism of nitrogen, 
which takes place through the intermediary of p- 
aminobenzoic acid and peptone in the case of strep- 
tococcus haemolyticus, and that the rôle of p- 
aminobenzoic acid and peptone is to form, with the 
appropriate enzymes, an enzyme substrate complex 
by virtue of the three chemical factors - NH2, 
000H, and the benzene nucleus. The enzyme sub- 
strate complex is then catalytically broken down 
with/ 
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with the liberation of the enzyme, which is free to 
continue with further appropriate substrate, and 
easily assimilable nitrogen necessary for the life 
of the organism. 
If we examine the chemical structure of sulph- 
anilamide it is seen that only two of these chemical 
factors - NH2 and the benzene nucleus - are present. 
It has been shown that substances with related 
chemical structure to that of a normal substrate 
can combine with the enzyme. The enzyme substrate 
so formed does not break down, thus preventing the 
enzyme from combining with the true substrate. 
This is called in bio- chemistry a "competitive 
inhibition." In view of this, they state it is 
reasonable to assume that sulphanilamide can com- 
bine with the same enzyme or enzymes of the bacter- 
ial cell to form an enzyme substrate complex which 
is not broken down and prevents the enzyme so com- 
bined from re- uniting with the true substrate (p- 
aminobenzoic acid and peptoneo) 
To summarise, when sulphanilamide is Given in 
human infection its action is as follows:- 
(a) It penetrates to the blood stream in an unal- 
tered form. 
(b) Thus dissolved in the blood and then the other 
body fluids it goes to the site of infection. 
(c) Bacteriostatic/ 
- 20- 
(c) Bacteriostatic action on the organism. 
(d) Direct action on the organism causing degen- 
erative changes mostly in the case of the 
pneumococci . 
(e) Absorption of the invading organisms by the 
naturally produced antibodies or leucocytes 
which are not interfered with by the drug. 
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Toxicity of the Sulphanilamides . 
In the treatment of gonorrhoea with sulphanil- 
amides one must be on the look -out for any toxic 
symptoms. It might be as well to divide these into 
their various classes. 
General effects. Some patients complain of gastro- 
intestinal symptoms, headache, dizziness, mental 
depression, and occasionally mental confusion. 
Gastro -intestinal symptoms are amongst the common- 
est symptoms generally mentioned by patients - 
especially women. Also nausea, actual vomiting, 
and diarrhoea. Sowie in 1939 reports that with 
intensive doses the gastric upset may be as high 
as 66%. 
Headache, dizziness, mental depression and confu- 
sion. Prebbler in 1938 had 1 case of very severe 
headache, and Lloyd in 1938 reported headache, 
dizziness, fainting and depression in 10 out of 
108 patients. Various authors advise caution to 
motorists and airmen who are taking the sulphanil- 
amide as it may completely upset their sense of 
control and be a danger to themselves and to others. 
Skin eruptions. These are rarely severe but may 
be morbilliform, scarlatiniform, urticarial, and 
24 
light sensitization. David Erskine gives a paper 
on dermatitis from sulphonamide compounds in which 
he sug.ests that there are two types of cases which 
may/ 
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may develop a rash, one which eliminates the drug 
and may have a true sensitization to it, and the 
other which retains the drug, and this may be a 
toxic result by failure of the eliminator. Rupert 
25 
Hallam urges care as the sulphanilamide may in 
some cases photosensitize the skin and produce a 
severe rash on exposure to strong sunlight, espec- 
ially in the tropics, or in ultra violet light 
treatment. 
Haemotopoietic system. The sulphanilamides may 
affect the bone marrow, and cases may be met with 
of agranulocytosis and haemolytic anaemia, also 
sulphaemoglobinaemia or methaemoglobinaemia with 
26 
cyanosis and slight dyspnoea. Nichol and Freedman 
had a fatal case of agranulocytosis in a male 
patient who received 68 grammes in 21 days, but 
generally speaking, reactions of blood condition 
are mild. 
Kidney. Cases have been noted where patients tak- 
ing the sulphanilamides have had haematuria, but 
most of these have occurred when the fluid intake 
was reduced, or in hot climates, as crystals of the 
acetyl derivative may be formed in the kidneys. 
27 
Cooper and Lewis however, report that owing to the 
relative insolubility of the sulphanilamides, 
urinary calculi were found in rats which were given 
1 gramme per kg. of body weight. These calculi 
consisted/ 
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consisted main l: of the acetyl derivative. They 
point out that although up to the present there 
has been no evidence of similar effects in man, 
small deposits may be formed during treatment over 
a long period with they assume a large size with 
serious results. 
The latest drug of the sulphanilamide group to 
be introduced is sulphathiazole or M & B 760 pro- 
duced by May & Baker which has the following form- 
ula. 
C CH 
NCH-'//  - 
II \\ ---- 
N CH 
SO2 
Experimentally and chemically it is less activ 
than M & B 693 in the treatment of oneumococcal in- 
fection, and perhaps also in gonococcal and menin- 
gococcal infection, but the evidence of nausea, 
vomiting, and various cerebral effects are seen to 
be less, so it could be used when M & B 693 is not 
well tolerated. 
28 
Ivioeschlin and Hurschler claim it is much less' 
toxic for the red cells than sulpha_ay ridine . They 
noticed that in the blood of about 50% of patients 
receiving sulphapyridine some of the red cells when 
stained supravitally with brilliant cresyl blue 
showed a definite intracorpuscular granule situated 
as/ 
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as a rule at the periphery of the cells. In 
patients treated with sulphathiazole the red cells 
did not show these granules. The nature of these 
intracorpuscular granules is not known but they 
have been found when methaemoglobin formation has 
occurred and may be produced by haemolytic drugs: 
they seem to be definitely connected with the toxic 
action on the red cells and hence the authors con- 
clude that sulphathiazole is less toxic than sul- 
phapyridine. They give a chemical explanation and 
suggest that the absence of the pyridine ring makes 
it less toxic to red cells. Sulphathiazole is ex- 
creted more rapidly than sulphapyridine and the 
maximum concentration of sulphathiazole in the 
serum is neither so high nor maintained for so 
29 
long, so Gaisford and Whitelaw suggest in pneu- 
monia giving sulphapyridine at first to get maxi - 
mum concentration and gradually to replace with 
sulphathiazole in subsequent doses, which course 
might be adopted in gonorrhoeal infections. 
30 
V. C. Lloyd and David Erskine have tried it 
in gonorrhoea with good results. Response to 
treatment was rapid and there was no evidence of 
intolerance. They gave 4 grammes daily for 5 days 
to 19 patients. In 13 cases the discharge cleared 
up in 2 days, and in only 1 case was it prolonged 
beyond 5 days. Of the 19 patients, 14 were under 
observation/ 
- 25 - 
observation for 5 to 9 weeks, and there was no re- 
currence. The other 5 were defaulters, but there 
is no reason to suppose they were not cured. 
31 
J. Gaté and Pluillaret reported good results in 
the treatment of acute gonorrhoea with suiphathia- 
zole. Up to December 1939 they had treated 68 
patients, 9 grammes were given over 24 hours, and 
a single day's treatment rapidly cleared the Bono- - 
out 
cocci from the urethra with /any local measures. 
All the patients were cured as established by a 
careful follow -up with provocative tests. 
Tolerance was good. There was one case of cyanosis. 
There appears to be no specificity in the 
action of any of these drugs in bacterial infection. 
One drug is not better for one type of infection 
and another for another type, as is the case in 
protozoal disease where we find quinine active 
against malaria, and the arsenicals in spirochaete 
infection. 
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Treatment of Gonorrhoeal Infections - The Male. 
Before treatment is started the patient's 
personal history is enquired into, his age, occu- 
pation, whether he is married or single, and if he 
has had previous attacks of venereal disease. An 
endeavour is then made to find out the approximate 
date of infection and the date of appearance of the 
first symptoms. A full clinical examination is 
carried out. Smears are made from the urethral 
discharge, if any, by Gram's method (Jensen's modi- 
fication) and examined at once. The urine is then 
passed into two test glasses and it is noted if 
these are cloudy or clear so as to eliminate pos- 
terior infection. If doubt exists regarding the 
diagnosis, blood is taken for the gonococcal 
Complement Fixation test and cultures of the secre- 
tion made. If the smear is positive, M & B 693 is 
given at once. Delayed chemotherapy is not prac- 
tised. Irrigation with potassium permanganate, 
1/8,000 is also started immediately at the clinic. 
If possible, the patient attends every evening for 
a week to irrigate under supervision of the orderly, 
or is instructed personally how to use a home 
irrigator which is provided at cost price. The 
dosage is as in the table. 
- 27 - 
Days 
Dosage in Grammes. 
Feriales Males 
1 3 3 
2 3 3 
3 3 3 
4 3 3 
5 3 3 
6 3 
7 3 
Total 15 Gras. 21 Gins. 
In females who do not always tolerate the drug 
as well as males, the dose would read 2 grammes 
instead of 3 grammes, and the total would be 14 
grammes. 
There are several points about dosage which 
must be impressed upon the patients. 
(1) They must take the tablets at certain fixed 
times so that the drug will be in the blood 
stream at its maximum all the time, say at 
7 a.m., 12 midday, and 6 p.m. - 2 tablets of 
sulphapyridine (M & ï3 693) . Night workers 
would take them at different times. 
(2) They must go on taking them even if they feel 
sick or have other symptoms, or else report 
at the clinic for further advice before the 
supply is finished. 
(3) They must take only 2 at a time as ordered, 
not 3 or 4 at once if they forget a dose. 
(4) If they feel sick after a dose they should take 
the subsequent dose with a large draught of 
still lemonade sweetened with glucose. 
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I find with sulphapyridine that the prohibi- 
tion of food or drugs rich in sulphur is unneces- 
sary, but no alcohol must be taken until allowed. 
The patient reports in a week's time and en- 
quiries are made as to any toxic symptoms. He is 
then examined for any discharge, and if present 
this is examined. Urine is passed into two glasses, 
and it is noted whether this is clear or cloudy. 
If there is no discharge and both glasses are clear, 
all treatment is stopped. The following week the 
same tests are done and if negative the patient is 
given a provocative dose of 200 million gonococcus 
vaccine - St. Thomas' Hospital brand marketed by 
Boots - and told he may take alcohol. He is fully 
examined again the next week, and if negative the 
prostate and seminal vesicles are massaged and any 
discharge examined for gonococci. If clear, he re- 
ports the following week and bougies are passed, 
10/20 French guage posterior, and the largest the 
meatus will admit anterior, and the urethra is 
massaged over them. If after examination a week 
later there are no symptoms of recurrence he is 
discharged as cured. 
If I find after a week's intensive course of 
sulphapyridine that there is still a discharge 
which is positive, I give another course and have 
rarely found this does not cure a patient. Some 
patients/ 
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patients are, however, "drug resistant ", i.e. 
partially or completely unaffected by the drug. 
These patients may be divided into three main 
groups. 
A Those how have had previous inadequate treatment 
with sulphapyridine or other sulphanilamides 
(1 tablet 3 times a day). It is better to wait 
at least fourteen days before beginning again 
with adequate doses and to rely in the meantime 
on irrigation with potassium permanganate 
18,000 and vaccine treatment. 
B Those who because of mild toxic symptoms do not 
persevere with the drug and take inadequate 
doses. Here one must impress upon the patients 
the importance of taking the drug as ordered. 
They must start the treatment again after four- 
teen days, relying until then on irrigation and 
vaccines. 
C Those who have any complications such as gonoeo- 
cci buried in the crypts in the urethra. These 
may well be the intracellular type of gonococci 
mentioned by D. J. MacKinnon, which in his 
series of cases seemed resistant to the sulphan- 
ilamide, and this will clear up after massage of 
the urethra over bougies, and massage of the 
prostate and seminal vesicles per rectum. If 
during treatment there is a relapse in any of 
the/ 
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the patients, with a positive smear, and four- 
teen days have elapsed since the patient has 
taken sulphapyridine, he restarts treatment and 
goes through the five weeks' course. If serious 
toxic symptoms appear during the treatment it is 
understood that the blood will have to be ex- 
amined in cases of cyanosis or breathlessness, 
the urine for blood if there were nephritic 
symptoms, and the skin if rashes appeared. 
All these complications would indicate over - 
dosage or non -elimination, or an idiosyncrasy 
to the drug, and the treatment would have to be 
suspended for the time being, the patient con- 
tiauing with simle irrigation and an alkaline 
mixture and vaccines. 
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The Gonococcal Complement Fixation Test. 
I have employed this test in several cases but 
find that with the sulphanilamides its use is lim- 
ited, as when it is understood that the test is a 
serum reaction which registers the presence or 
absence of specific gonococcal antibodies in the 
blood, and that these are rarely present in the 
early uncomplicated stages of the disease if ade- 
quately treated with sulphapyridine, one finds the 
test is nearly always negative. But for determin- 
ing cure, a series of these tests is most useful, 
as a strongly positive, diminishing gradually to 
negative, is very good evidence of cure. Also, at 
a certain stage in the disease (varying in differ- 
ent people) a positive Gonococcal Complement 
Fixation test is regarded as being a good sign, 
showing the presence of antibodies, and that natur- 
al immunisation is taking place. Similarly, a 
negative result may be a bad sign if the disease 
has been present for a number of weeks or months. 
And in the neglected case when the disease has 
reached the posterior urethra with involvement of 
the seminal vesicles and prostate which may lead to 
a condition of "closed" infection, and the material 
is absorbed into the blood stream, we get a strongly 
positive Gonococcal Complement Fixation test, and 
without positive clinical signs such as a dis- 
charge, the test is of great importance. 
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Treatment in Women. 
Here the chemotherapy is the same but women 
require different management and estimation of 
cure. I find they report toxic symptoms more than 
men, especially headache and nausea, but I endeav- 
our to give the same dose and for seven days instead 
of five as they seem more resistant to the drug. 
The personal and clinical histories are taken, and 
whether married or single - an important point for 
later re- infection by the husband. Then smears are 
taken from the urethra and cervix uteri, and if re- 
quired, from Bartholin's gland. These are sent to 
the adjoining Pathological Department, but if from 
the history and clinical signs gonorrhoea is sus- 
pected, treatment is begun at once. Blood is taken 
for the Gonococcal Complement Fixation test, and 
vaginal douching and urethral irrigation are 
carried out with a glass nozzle of the London Hos- 
pital pattern. Potassium permanganate 1 /8,000 is 
used for both as a routine. This is done daily at 
the clinic or at home. Usually only vaginal douch- 
ing is demonstrated, but in exceptional cases 
urethral douching is also demonstrated. If the 
smear taken at the start is positive, the patient 
reports every week for seven consecutive weeks. 
Smears are taken at these intervals and the Gono- 
coccal Complement Fixation test at the sixth week. 
If/ 
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If the patient has a negative smear, however, but 
a positive Gonococcal Complement Fixation test 
after clinical signs have disappeared, the Gonoco- 
ccal Complement Fixation test is repeated monthly 
until negative. 
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Cases and Discussion. 
In the study of cases of gonorrhoea treated 
with sulphanilamide, I have attempted the following 
procedure. In assessing its value I was of the 
opinion that the best method would be to compare in 
detail the treatment of patients in the pre-sulph- 
anilamide days (i.e. with irrigation and an alka- 
line mixture), the sulphanilamide days, with 
sulphapyridine (Dagenan M & 3 693), and with the 
latest drug sulphathiazole or "Thiazamide" 
(M & B. 760) . On looking up old cases I find the 
first series to be treated consistently with sulph- 
anilamide was begun on December 29th 1937, and the 
last on the 25th August 1938, eight months in all 
during which 60 cases were treated, the majority 
being male. I then chose the 60 before those, 
treated by irrigation and vaccines and the 60 
following, treated by sulphapyridine (M cc 3 693), 
and lastly the few treated by sulphathiazole 
(M (Sc B 760) . These four groups, three of 60, I 
tabulated under thirteen headings (see over), which 
I hoped would give me sufficient data to work on. 
To see how the cases treated this year by sulpha - 
pyridine (M & B 693) had fared, I also took all the 
cases discharged and who ceased to attend after 
completion of treatment up to September 30th 1940, 
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before discussing the results I obtained, I think 
it necessary to define some terms I have used. 
Cured or Discharged after completion of 
Discharged - treatment and observation (including 
routine tests). 
Ceased A or Any patient who ceased to attend 
Defaulters - before completion of treatment. 
Ceased B or Any patient who ceased to attend 
Apparent after completion of treatment but 
Cures - before completion of observation 
period and tests. 
Relapse - Any patient who has a return of 
symptoms and signs, with a positive 
smear, who as far as could be estab- 
lished had not re- infected himself. 
Drug ' Jhere the patient with adequate 
Resistant - doses of the drug still continues 
with a positive smear. This is, 
in most cases, acquired when the 
patient has been previously treated 
with inadequate doses of the sulph- 
anilamides, or had a closed infec- 
tion after complications. 
It might be as well here to give the treat- 
ment adopted in this series of cases. 
A. Pre- sulphanilamide Treatment, Daily irrigation 
with 1/8,000 potassium permanganate for 3 weeks 
or/ 
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or as long as the discharge continues, and an 
alkaline mixture and vaccine treatment. 
3. Sulphanilamide Treatment. 
1st week 1 gm 3 times a day) 
2nd " 1 gm " te t " ) 52 gms . 
3rd " .5 gm rt rt ti u ) 
All with irrigation with 1/8,000 potassium per- 
manganate. 
C. Sulphapyridine Treatment (M u B 693) . 
See previous "Treatment of Gonorrhoeal 
Infection." 
Tow let us discuss the 180 cases in more de- 
tail and tabulate them. 
Table 1 Results of Treatment Males 
Apparent 
Cures Defaulters iR) Cures 
Irrigation L'u 
__._ 
Mixture 60 33(55%) 1l(18ó} 
Sulphanilamide 
& Irrigation 60 26(43%) 16(26%) 
Sulphapyridine 









& Irrigation 60 
Sulphapyridine 
(M & B 693) 60 
Bales 
Drug .Compli- Re- 
Resist. cation lapses Toxicity 
12(20%) - 
2(3%) 9(15 %) 12(20%) 16(26 %) 
5(8 %) 7(l1%) 6(10 %) 28(46%) 




Days under Treatment 
Irrigation cJ2 
Mixture 60 1T 75 
Sulphanila- 
mide 60 tt 55 
Sulphapyridine 
( M B 693) 60 tt 52 
Up to Sept 30, 
1940. 15 It 41 
Table 4 Male s 
No Length of time for 
discharge to clear up 
Irrigation cc 
Mixture 60 28 days 
Sulphanilamide 60 7 -12 " 
Sulphapyridine 
(M & B 693) 60 1 -2 " 
In 23 cases (38 %) dry the day following. 
Table ,5 Males 
Cases Cured and Apparently Cured 
up to Sept. 30, 1940 
Days under 
No Cured Aupar. treatment 
Cured for Cured 
Cases 




Dry Toxi -e- 
in city lapse 
48 
hrs 
16 9 1 
2 cases - one with a positive Gonococcal Complement 
Fixation test and the other with epididymitis - 
took 293 days to be discharged. These are not in- 
cluded in the above. 
Now/ 
- 38 - 
Now let us analyse these tables a little more 
fully from the point of view of percentage. To my 
surprise, we seem in Table 1 to have had more cures 
with irrigation and medicine than with the sulph- 
anilamides but I think this may well be explained 
by looking at Tables 3 and 4. In Table 3 we see 
that with irrigation the average time for cure is 
seventy -five days, while with the sulphanilamides 
the average time for cure is roughly fifty days. 
We therefore keep an eye on the patients for a 
longer period, and they get into the habit of com- 
ing to the clinic for irrigation daily. What I 
think is of more importance is that the discharge 
with the sulphanilamide is cleared up in a day or 
two, or in the case of sulphapyridine (M & B 693) 
in adequate doses in 38% of cases in twenty -four 
hours as shown in Table 4 and 5. The patient, 
feeling well and with no discomfort or discharge, 
discharges himself however much he is advised to 
report again. In Table 1 this point is brought out 
when we get with the sulphanilamides 30% of default- 
ers, and it is to be hoped that these 30%, and the 
26% and 20% of apparent cure are definitely cured 
and have not spread gonorrhoea to the community. 
In comparing sulphanilamide with sulphapyridine 
(M & B 693) regarding cure we find sulphapyridine 
cures 50% of cases and sulphanilamide 43,`'ßo If we 
add/ 
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add apparent cures to the former we get 70% and to 
the latter 69 %. There is therefore not much to 
choose between them except that with sulphapyridine 
you get your result with, in most cases, 15 grammes 
of sulphapyridine, and 522 grammes of sulphanila- 
mide - the latter with more risk of toxic effects, 
or of the patient neglecting his treatment. 
Relapses, Complications, and Drug Resistance. 
I have grouped these three together because 
in several of the cases of relapse it lias been 
found that this was due to inadequate doses of 
sulphanilamide previous to attending the clinic. 
I have included in the relapses those cases which 
relapsed after sulphanilamide or after sulphapy- 
ridine before reaching the clinic. In most other 
cases the relapses were due to some complication 
either arising during the treatment, which was 
rare, or already existing when the patient came 
under observation. These relapses are so important 
that I will give them in some detail. 
Case 1 
A man aged 34 came to the clinic on the 23rd 
August 1937. There was a copious urethral dis- 
charge of pus which had started the same day. This 
was found to be G.C.t. Posterior irrigation with 
1/8,000 potassium permanganate was begun and an 
alkaline mixture given. This treatment was 
continued/ 
- 40 - 
continued until the 13th September when all dis- 
charge had ceased. Tests for cure were undertaken, 
but on the 1st December the discharge recurred 
(G.C.i) . Irrigation was resumed and 1 gramme of 
sulphanilamide was given 3 times a day for 1 week. 
The next week he had no discharge and another 1 
gramme 3 times a day was given. He subsequently 
discharged himself but on the 16th January 1938 he 
was re- admitted with a copious urethral discharge 
(G.C.-t-). He was again given sulphanilamide in the 
usual dose for 3 weeks - 52z grammes - but in the 
course of observations for cure had a slight dis- 
charge on the 14th Larch which was G.C.D. Irriga- 
tion was resumed and a vaccine given up to 400 
millions on the 13th April, when he discharged him- 
self again, one hopes cured. 
Comment A case given adequate treatment with 
sulphanilamide and having no complication which 
relapsed three times. 
Case 2 
A Labourer aged 26 came to the clinic on the 
6th February 1938 with a copious urethral discharge 
(G.C. +) which had started on the 6th February. He 
had had no previous treatment. He was put on the 
usual dosage of sulphanilamide, suffered no toxic 
effects, and was dry on the 9th March. On the 
14th March the discharge re- commenced (G.C.-t -) . 
Irrigation/ 
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Irrigation was started again and a vaccine given. 
He came to the clinic on the 13th April with a dis- 
charge which had started again on the 11th April. 
This was also G.C.t. Vaccine treatment was con- 
tinued, but on the 11th May he had difficulty with 
micturition, but no discharge. On the 18th May his 
trouble with micturition became worse, and on ex- 
amination his seminal vesicles were painful. He 
was given Uleron for 4 days - 1 gramme 3 times a 
day. On June 8th all symptoms had cleared up and 
he was discharged on the 13th July. 
Comment A case given adequate treatment with 
sulphanilamide which relapsed evidently with the 
complication of vesiculitis but cleared up with 
Uleron and vaccine treatment. 
Case 3 
A Farmer aged 31 came to the clinic on the 
16th February 1938 with a copious urethral dis- 
charge (G.C.t) which had started on the 25th 
December 1937. He had had no previous treatment. 
He was given the usual sulphanilamide treatment and 
irrigation, and the discharge cleared up on the 
2nd March. He came to the clinic on the 16th March 
with a discharge (G.C.t) which had started again on 
the 12th March after influenza. He was given vac- 
cine treatment and irrigation, but having been dry 
on the 23rd March had á copious discharge (G.C.t) 
on/ 
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on the 30th. Irrigation was resumed and vaccine 
treatment continued. He was dry on the 21st April 
but carne to the clinic on the 1st June with a copi- 
ous discharge (G.C.t) which had started on the 
28th May. He was examined per rectum and his 
seminal vesicles were very painful. Irrigation was 
again carried out and on the 23rd June his symptoms 
were gone. On the 6th July he had a copious dis- 
charge (G.C.t) with painful prostate and seminal 
vesicles. He was given Uleron, 1 gramme 3 times 
a day for 1 week. The discharge ceased but on the 
3rd August he had a slight urethral discharge 
(G.0 .4.) and was given M & B 693, 1 gramme 3 times 
a day for 10 days. He had a violent headache so 
only took them for 6 days. These cleared up the 
discharge, and having passed all tests he was dis- 
charged on the 14th September 1938. 
Comment A case given adequate treatment with sulpha. 
anilamide which relapsed after influenza; again 
relapsed after vesiculitis, failed to be cured with 
Uleron but was cured with adequate doses of sul;)h- 
apyridine (M ¿: B 693) . 
Case 4 
A Labourer came to the clinic on the 23rd 
February 1938 with a copious urethral discharge 
(G.C.t) which started on the 10th February. No 
previous treatment. He was apparently cured with 
42/ 
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42 grammes sulphanilamide on 16th March 1938, dis- 
charged himself, but came to the clinic on the 22nd 
June with a urethral discharge (G.C.j -) . Ile was 
also suffering from arthritis of the knees. He was 
apparently cured with 522 grammes sulphanilamide on 
the 20th July, but discharged himself while under 
observation. 
Comment. A case given adequate treatment with sul -1 
phanilamide which relapsed. There was a possibil- 
ity of re- infection from his wife, an old patient, 
but the arthritis raay have caused his relapse. 
Case 5 
A Gardener aged 18 came to the clinic on the 
10th March 1938 with a copious urethral discharge 
(G.C.t) which had started on the 9th March. No 
previous treatment. He was treated with 522 
grammes sulphanilamide but relapsed with a urethral 
discharge (G.C.f) on the 6th April, 25th May and 
15th June, when he had balanitis. He was given 
3 "stosses" of Uleron for 4 days, and after the 
last failed to report. One hopes he was cured. 
Comment. A relapse after adequate doses of sul- 
phanilamide, and perhaps cured with Uleron after 
balanitis. 
Case 6 
A Baker aged 29 reported at the clinic on the 
21st March 1938 with a copious urethral discharge 
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(G.C.*) of one day's duration. He was treated with 
522 grammes sulphanilamide but relapsed on the 4th 
May 1938 with slight urethral discharge (G.C.t). 
Bougies had been passed the week before. He dis- 
charged himself on the 11th May 1938 with a slight 
negative discharge. 
Comment A relapse after adequate doses of sulph- 
anilamide and after passage of bougies. Possible 
infection of Littré's glands. Discharged himself, 
most likely in an infectious condition. 
Case 7 
A Labourer aged 40 reported at the clinic on 
the 9th March 1938 with a copious urethral discharge 
(G.C.t) of five days' duration. Treated with 522 
grammes sulphanilamide and bougies passed on the 
6th April. Resolved Littré's glands, palpable, not 
tender on passage. No discharge afterwards, but on 
the 13th May slight urethral discharge (G.C.t'). He 
was discharged on the 1st June 1938. On the 13th 
July he again came to the clinic with a history of 
discharge dating from the 9th July. On examination 
there was aimethral discharge (G.C.t). He was 
given sulphapyridine (I: B 693) , 1 gramme 3 times 
a day, and discharged himself on the 17th August 
1938 after bougies had been passed. 
Comment A relapse with sulphanilamide after infec- 
tion of Littré's glands. Apparently cured by sul- 
phapyridine (M & B 693). 
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Case 8 
A Steel Erector aged 36 came to the clinic on 
the 30th March 1938 with a copious urethral dis- 
charge (G.C. -r) of one day's duration. Treated with 
522 grammes sulphanilamide. Bogies passed on the 
27th April. Relapsed (G.C.fi) on the 4th .play. Dis- 
charged himself on the 12th June 1938. 
Comment A case very similar to No. 7. 
Case 9 
A Chauffeur aged 32 reported at the clinic on 
the 2nd June 1938 with a copious urethral discharge 
(G.C.t) of seven days' duration. No previous treat- 
ment. Treated with sulphanilamide, 522 grammes, 
Slight discharge with pus cells until the 22nd June. 
Copious urethral discharge on the 29th June (G.C.*). 
Given vaccine treatment, and discharged himself on 
the 3rd August apparently cured. 
Comment A relapse after sulphanilamide, no compli- 
cations but discharge with pus cells continued for 
some time, becoming positive. 
The following three cases relapsed after sul- 
phanilamide but were discharged cured with sulpha - 
pyridine (M á: B 693) . 
Case 10 
Male attended the clinic on the 15th June 1938 
with copious discharge (G.C.fi). Relapsed on the 
28th July after sulphanilamide, 522 grammes. Given 
sulphapyridine/ 
sulphapyridine, 21 grammes a week and 12 grammes 
for 4 days. Discharged on the 8th September cured. 
Case 11 
hale came to clinic on the 7th July 1938 with 
a copious discharge (G.C.1I-). Relapsed on the 3rd 
August after sulphanilamide, 52i grammes. Given 
sulphapyridine, 21 grammes a week and 12 grammes 
for 4 days. Discharged on the 14th August cured. 
Case 12 
Tale attended the clinic on the 16th June 1938 
with copious urethral discharge (G.C. +). Given 521- 
grammes sulphanilamide. Relapsed on the 13th 
August. Given sulphapyridine, 21 grammes a week and 
12 grammes for 4 days. Discharged on the 7th 
September cured. 
Case 13 
This case is of some interest so is given in 
more detail. A Joiner aged 50 came to the clinic 
first on the 25th August 1937 with a copious ureth- 
ral discharge (G.C.+) of one weekTs duration. He 
had been given medicine by his private practitioner 
which had failed. He also had paraphimosis and was 
put on twice daily irrigation with potassium per- 
' manganate. The copious discharge continued, and on 
the 15th September he complained of pain in both 
testicles. On the 22nd September he had a right 
epididymitis which was treated with ichthyol and 
glycerin / 
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glycerin and 1 c.c. Antitoxin (Park Davis Co.) 
which cleared up the epididy i tis. On the 29th 
September he had a slight purulent discharge (G.C.-i-) 
which disappeared on the 13th October and he was 
discharged on the 24th i:ovember 1937. He was re- 
admitted on the 14th July 1938 stating that the dis- 
charge had recurred on the 11th and that he had pain 
on micturition. On examination, he had a clear dis- 
charge, very slight G.C. -. His G.C.F. however was 
strongly positive. On the 27th July he was given 
sulphanilamide, 1 gramme t.i.d. for a week, but was 
unable to take it owing to old gastric trouble. He 
was told to report for G.C.F. in two months' time. 
He returned on the 29th September and his G.C.F. 
was again positive. He reported on the 13th 
October and was put on 2 '=stosses" of Uleron, 1 
gramme 3 times a day for 4 days. On the 10th 
Novemoer he was feeling very well, no discharge, 
but G.C.F. still positive. On the 27th July he re- 
ported for a G.C.F. and this was negative. 
Comment This cure is of interest for two reasons. 
Firstly, that a man who could not tolerate sulph- 
anilamide because of old gastric trouble was not 
upset by Uleron. Secondly, it shows the value of 
the Gonococcal Complement Fixation test for cure in 
long- standing cases, and if one has the co- opera- 
tion of the patient, he can be given a certain cure 
even after 2 years. 
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Drug Resistant Cases and Relapses. 
The following cases are some which relapsed or 
which have not been cured by inadequate doses of 
the sulphanilamides, i.e. drug resistant cases. 
Case 1 
A Van Driver aged 29 was sent by his doctor on 
the 12th December 1938 because treatment had failed. 
It was found that he had had an initial treatment 
of 1 tablet sulphanilamide 3 times a day from the 
8th December. There was a copious urethral dis- 
charge (G.C.1-). Posterior irrigation with potassium 
permanganate 1/8,000 was begun, and 1 gramme suiph 
apyridine (M ¿ B 693) was given 3 times a day for 
5 days. All clinical signs disappeared on the 21st 
December. The G.C.F. was done and was negative. 
He was discharged cured after all tests on February 
1st 1939. On the 2nd March 1939 he was re-admitted 
stating that on two occasions he had had a slight 
urethral discharge. On examination, there was a 
definite slight discharge (G.C. -f-) . The G.C.F. was 
still negative. He was given 1 gramme sulphapyri- 
dine (M & B 693) 3 times a day for 1 week. Clinical 
signs ceased on the 9th March and he was discharged 
cured on the 5th April 1939 having passed all tests 
for cure. 
Comment A typical case of drug resistance result- 
ing from inadequate doses. 
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Case 
A Joiner aged 27 was sent by his medical atten- 
dant on the 11th January 1939 because treatment had 
failed. It was found that he had had an initial 
course of streptocide, 4 tablets daily, since the 
28th December 1938, but the discharge had never 
ceased. Iie had had no tablets for 4 days before 
coming to the clinic. On examination he had a pur- 
ulent urethral discharge (G.C.fi). Posterior irri- 
gation with potassium permanganate 1/8,000 was 
begun, and he was given sulphapyridine (M & B 693) , 
3 grammes for 5 days. He reported on the 10th 
January stating that he had for some reason only 
taken 4 tablets and still had a copious discharge 
of pus (G.C.t) . The dose of sulphapyridine (M & B 
693), 3 grammes daily was repeated, and he went 
through all the tests until the 15th February 1939. 
On the 27th February he again had a purulent dis- 
charge (G.C. +) and was given sulphapyridine (Li & B 
693), 3 grammes daily for 7 days. All clinical 
signs disappeared in 1 week, and having gone through 
all the tests for cure he was discharged on the 5th 
April 1939. 
Comment Another typical case of drug resistance 
owing to inadequate doses, showing also that it is 
no use giving adequate doses after too short an 
interval before the patient loses his drug 
resistance/ 
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resistance. Irrigation must be relied upon in the 
interval, and vaccine treatment. 
Eight other cases came to the clinic, 6 in 
1939 and 2 in 1940, having previously been given 
inadequate doses, and these are tabulated below. 
Previous 
Sex Age Treatment 1st Attendance Relapse 
l.Male 24 gm. sul- 30.1.39 G.C.+ Nil 
phanila- 
mide t.i.d. 
2.Male 31 4 tablets 9.2.39 G.C.+ Nil 
daily M & 
B69321.1. 
39. to 23. 
1.39. 2 tab- 
lets daily 













M&B 693 31.3.39 G.C.+ 20.11.39. Trans - 
4 tablets ferred 
daily for 12.4.39. 
9 days. 
Sulphanil- 9.11.39 G.C.+ 412.39. Ceased B 
amide 1 10.1.40. 
t.i.d. for 
4 days. 













Dean St. 20.12.39.G.C.+ 3.1.40. Ceased A 
Hospital 24.1.40. 
M &B 693? 
discharged 
6 mths ago. 
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Previous 
Sex Ao'e Treatment 1st Attendance Relapse Result 
7.. Tale 38 M&B 693, 21.2.40 G.0.+ 13.3.40 Ceased B 
2 t.i.d. 3.4.40 5.6.40 
for 4 days 
M&B 693, 
1 t.i.d. 
for 8 days. 
Interval 2 
days. M&B 
693 1 t.i.d. 
for 7 days 






In these eight cases 2 who discharged theca- 
selves - cases 6 and 8 - were most certainly still 
infective. 
On looking up sixty previous cases at the clin- 
ic I could find onl one which relapsed without com- 
plication after adequate doses of sulphapyridine 
(M & B 693) . 
A Gardener aged 40 came to the clinic on the 
26th April 1939 with a copious purulent discharge 
(G.C.t) which had started on the 12th April. He had 
had no previous treatment. lie was given sulpha - 
pyridine, 3 grammes daily for 5 days, and irriga- 
tion. All clinical signs disappeared in a week, bu 
the following week he again had a discharge (G.C. -t-) 
and was given sulphapyridine, 3 grammes daily for 7 
days. The week after, clinical signs again disap- 
peared, but unfortunately he then discharged him- 
self without undergoing tests for cure. 
Comment A case treated adequately with sulphapyri- 
dine (M & B 693) which relapsed for no explained 
reason. 
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Cases with Toxic Symptoms 
In the cases which I have reviewed treated with 
sulphanilamide and sulphapyridine (M B 693), toxi- 
city has never been marked but has been more in evi- 
dence with sulphapyridine (46ó) than with sulphanil- 
amide (26jó) . Headache was the chief complaint in 7 
patients treated with sulphanilamide and in 11 
patients treated with sulphapyridine. Rashes fol- 
lowed the sulphanilamide treatment in.6 cases, and 
in i case after sulphapyridine. This is what one 
might expect on comparing the different doses, 52L- 
grammes and 15 grammes. I had no case of nausea or 
sickness with sulphanilamide, but 3 cases of nausea 
and 6 with actual vomiting after sulphapyridine 
B 693) . 1 case of dizziness occurred with 
sulphanilamide, and 5 with sulphapyridine. The last 
complaint, tingling of the hands and feet, was un- 
common in both sulphanilamide and sulphapyridine. 
Comparing these results with those of other 
workers, I found in the case of F. J. Bowie that out 
of 30 cases treated with the same dose of sulpha- 
pyridine (h B 693) he had 7 toxic results. He 
had only 1 case of headache to my 11 cases in 60; 
2 cases of nausea to my 3, and he had no case of 
actual vomiting whereas I had 6. Scottish stomachs 
must be stronger than English! He had 2 cases of 
dizziness to y 5, and no case of rash as compared 
with 
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with my 1 case. He reports, however, 1 instance of 
breathlessness in a patient and 1 instance of drove 
32 
siness, complaints I did not encounter. Somerville 
after using the some dose of sulphapyridine had 76 
cases out of a total of 152 which showed toxic 
symptoms, which are much the same results as mine, 
as also are his headache results of 26. To his 3 
instances of vomiting and 30 of nausea I had G cased 
of vomiting and 3 of nausea. His rashes were 3 to 
my 1 in half the cases, and his instances of dizzi- 
ness were 6 to my 5. Somerville states that he 
thought his dose, 3 grammes daily, produced too 
toxic effects. he reduced it to 2 grammes, and 
claims as good results. 
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The Gonococcal Complement Fixation Test. 
This test is most useful as an aid to diagnosis, 
in the absence of a positive microscopic test, as 
the following case shows. 
A Motor Driver aged 30 reported at the clinic 
on the 5th April 1939 with the following history. 
In January 1935 he had been treated at the Aberdeen 
clinic for eight weeks by irrigation with potassium 
permanganate but was not discharged. His smear was 
said to be negative, and he had had no urethral disi 
charge since. On examination there was no discharg- 
but his G.C.P. was strongly positive and he was 
given 3 grammes sulphapyridine (M u B 693) for 1 
week. On the 31st May his G.C.F. was still strongl 
Positive but on the 30th August came down to weakly 
positive, and finally on the 25th October to nega- 
tive. 
Comment A case with no clinical signs but found to 
have a strongly positive G.C.F. which was brought 
to negative in seven months by a full dose of 
ri & B 693. A G.C.F. should therefore always be 
done in su.soicious cases with a G.C. -. smear. 
The G.C.F. as a test for cure is not, however, 
a routine with the sulpb.anilamides, as when these 
are given early, in adequate doses, à positive re- 
skill; is never obtained. 'dhen the disease has been 
present for a month or more before treatment is 
begun/ 
- 55 - 
begun, the test is worth doing as there is some 
prospect of it having become positive. If a posi- 
tive result is obtained the test is repeated at 
intervals of one or two months until negative, but 
in the absence of all clinical signs it is, I think 
permissible to discharge a patient without waiting 
for a negative report if a descending series is 
obtained. 
I have one patient in mind, however, who has 
had no discharge, and clinically has been cured for 
years. The patient had an infection of the seminal 
vesicles which cleared up, but since 1937 he has 
had a strongly positive G.C.P. despite all treat- 
ment. I do not feel justified in advising surgical 
treatment for removal of one of the vesicles, though 
this might cure him as regards his strongly posi- 
tive G.C.F. 
In my series, this test was used on twelve oc- 
casions with sulphanilamide treatment, and in most 
cases it brought a strongly positive reaction down 
to a negative, or at least a doubtful negative when 
the patient could be persuaded to report at monthly, 
or two monthly intervals (see case 13). 
In the sulphapyridine series the test was used 
in nine cases, but here most of them were negative 
to start with. 
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Tkiiazarnide ( Sulphathiazole ) Iv7 B 760. 
I have only had the opportunity of using this 
drug in fourteen cases, as there is difficulty in 
getting it owing to war conditions. So far as it 
is possible to judge from this limited experience, 
sulphathiazole promises to be the drug of choice in 
gonorrhoea. Much greater experience will be requir- 
ed, however, before any definite conclusion can be 
reached. One of the advantages is that very large 
doses can be given in a short period of time, and 
a cure might be effected in twenty-four hours. 
In these fourteen cases of twelve males and 
two females receiving the same dose - 8 tablets 
daily for 2 days and 6 tablets daily for 3 days, 
34 tablets in all (17 gms.) - the only toxic sym- 
ptom occurred in a male who complained of listless- 
ness. In 9 male cases the discharge ceased in 24 
hours and in 3 cases in 48 hours. In one case, an 
intelligent male, I tried the intensive treatment 
31 
as advocated by J. Gate and Pluillaret - see case 
2 - but he had a relapse. The two female cases 
responded well to treatment. 
I now detail those cases of special interest. 
Case 1 
A Gardener -Chauffeur aged 24 came to the clin- 
ic on the 25th September 1940. There was a copious 
urethral discharge (G.C.t). Sulphathiazole was 
given/ 
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given as follows : - 2 tablets 4 times a day for 2 
days, and 2 tablets 3 times a day for 3 days - 34 
tablets in all. No local treatment was carried out. 
All clinical signs disappeared on the 2nd October. 
The patient stated that the discharge ceased on the 
26th September and that he had no toxic symptoms. 
He drank, contrary to instructions, considerable 
quantities of beer on the 27th September. He was 
given a provocative vaccine of 200 million on the 
9th October and discharged himself, one presumes 
cured. 
Case 2 
A bricklayer aged 25 came to the clinic on the 
11th December 1940 with a purulent urethral dis- 
charge G.C.-1". He was given sulphathiazole (M & B 
760), 3 tablets every 4 hours day and night for 24 
hours - 9 grammes in all - and daily irrigation with 
potassium permanganate 1/8,000. When he reported 
on the 12th December there was no discharge; the 
first glass contained threads and the second was 
clear; there were no toxic symptoms. On the 18th 
December he had a purulent discharge, G.C. t. and he 
was put on the usual dose of 8 tablets daily for 2 
days and 6 tablets for 3 days. He came to the 
clinic on the 1st January 1941, quite dry, and 
stated that the discharge had ceased on the 19th 
December. All treatment was stopped and he 
continued/ 
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continued to be free from discharge. He reported 
on the 8th January 1941 and was given a provocative 
dose of 200 million Vacc.A. He is still undergoing 
tests for cure. 
Comment A patient given intensive treatment with 
sulp_lathiazole who relapsed but so far has been 
cured with the ordinary dosage as adopted at the 
clinic. 
Case 3 
A married woman aged 27 who had been infected 
by her husband (under our care) came to the clinic 
on the 14th October 1940. On examination there was 
no urethral discharge but slight leucorrhoea. The 
urethral smear was G.C. -. but the cervical smear 
was G.C.1. She was given sulphathiazole, 8 tablets 
daily for 2 days and 6 tablets daily for 5 days and 
home irrigation with potassium permanganate 18,000, 
and her blood taken for the G.C.F. test. On report- 
ing on the 21st October there was no urethral dis- 
charge but a slight leucorrhoea. She had had no 
toxic symptoms whatever. Smears taken were G.G. 
and the G.C.F. doubtful. On examination on the 4th 
November there were no signs and her smears were 
again negative. Her blood was re -taken and the 
G.C.F. was negative. On the 9th December she was 
again examined and smears taken which were G.C. -. 
She then left the district, we hope cured. 
Comment/ 
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Comment A female with a doubtful G.C.F. and a posi 
tive cervical smear given sulphathiazole for a week, 
without toxic symptoms, and presumed cured. 
Case 4 
A Barmaid aged 21 came to the clinic on the 
12th December 1940. On examination smears were 
taken from the urethra and cervix. The former was 
G.C.-1-. She was given sulphathiazole, 8 tablets 
daily for 2 days and 6 tablets daily for 3 days, 
and daily douching with potassium permanganate 
1/8,000. The G.C.P. was negative. On the 23rd 
December the smears were negative and she had no 
toxic symptoms. On the 28th December the smears 
were again negative, and though she is still under 
observation, one hopes she is cured. 
Comment A female with a positive urethral smear 
given sulphathiazole without toxic symptoms. Still 
under observation but presumed cured. 
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The Sulphanilamides in Gonorrhoea in Women. 
I shall discuss women separately because al- 
though the chemotherapy is the same, the onset, 
course, and tests for cure differ to a great extent. 
On learning the history, rarely is a case found to 
be acute. They so often prove to be sub -acute from 
the start, or else chronic, and it is a question 
how long one must keep them under observation. 
lapses are common, but in the great majority of 
cases if the patients are carefully questioned they 
are found to be re- infections. 
Two points which I discovered in the case of 
women were, firstly, being much more prone to head- 
ache and sickness they complain of the toxicity of 
sulphapyridine (NI & B 693). Secondly, the G.C.F. 
test is essential, a test for cure in women being 
in most cases positive at the commencement of the 
treatment. 
The following are cases of gonorrhoea in women 
treated by sulphapyridine (M & B 693) which seem of 
interest. 
Case 1 
A Housewife, a married woman aged 43, came to 
the clinic on the 2nd February 1939. On examination 
there was no urethral discharge but the cervical 
smear was G.C.1 and the G.C. F. strongly positive. 
She was Given M & B 693, 1 tablet 4 times a day, 
and 
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and also vaginal irrigation. On reporting on the 
6th February, she stated that she had had severe 
headache and vomiting but had taken all the tablets. 
There was no urethral discharge but some vaginal 
discharge. All clinical signs disappeared on the 
13th February and the smears were negative. On the 
2nd March she was clinically free and the smears 
still negative but the G.C.F. was positive. It was 
still positive on the 30th March and she was told 
to report in 2 months' time for a blood test. On 
the 22nd May the G.C.F. was negative and there were 
no clinical signs. She was discharged cured. 
Comment A female patient with a positive smear and 
a strongly positive G.C.F. In four months the 
smears were negative and the G.C.I. brought down 
from strongly positive to positive and negative by 
sulphapyridine. 
Case 2 
A Shop Girl, unmarried aged 19, reported at 
the clinic on the 1st December 1933« On examina- 
tion, smears from the urethra and cervix were G.C.1- 
and G.C.2.t# She was douched daily at the clinic 
and given sulphapyridine, 1 gramme 3 times a day 
for 5 days. She complained of slight headache. The 
clinical signs disappeared on the 22nd January 1939 
and there was no recurrence. The G.C.F. was nega- 
tive on the 29th January when she discharged her- 
self. 
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Comment A young girl with positive smears and posi- 
tive G.C.F. who .was presumably cured in two months 
by sulphapyridine (Li B 693). 
I will give in tabular form the next three 
cases. 
Case 3 
Sex Age 1st Attendance Treatment G.C.F.Test Result 
3 !Female 32 13.3.39 M & B 693 413.3.39 Dis- 
2 gms -25.8.39 charged 
Smears- urethra daily for 25.8.39 
G.C.t 7 days Smears 
Smears -cervix negative 
GC 25.8.39 
4 2er,lale 29 17.2.38 
Case 4 
Sulphan- 4 17.2.38 Dis - 
ilamide -28.3.38 charged 
1 gm t.i.d 28.3.38 
for 2 wks Smears - 
5 gms t L . d 28.3.38 




5 Female 24 
Case 5 
15.12.38 M & B 693 +15.12.38 Dis- 
2 gms daily-23. 2.39 charged 
for 5 days 23.2.39 
Smears - 
23.2.39 
Comments I have given these three cases as examples 
where under treatment with sulphanilamides a favour- 
able result was obtained and the patient cured. 
There were numerous others, however, some with corn- 
. plications, who attended for months or discharged 
themselves without certain cure. 
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S U MMARY. 
I have endeavoured by referring to old and new 
cases, over 200 in all dating from the beginning of 
1937 to September 1940, to show how the sulphanil- 
amides have improved the treatment of gonorrhoea in 
the male and to a lesser extent in the female. I 
have used sulphanilamide and sulphapyridine (M & B 
693) and in a few cases sulphathiazole (M & B 760). 
Between the first two there is not much to choose, 
both being potent drugs. I have not had sufficient 
time to judge the possibilities of sulphathiazole. 
Sulphapyridine (M & B 693) is more rapid in its 
action than the sulphanilamides, and a lower dosage 
is used for a shorter time. It is also excreted 
more slowly. Sulphathiazole (M & B 760) seems in 
larger doses to be non -toxic, and is equally potent. 
In the majority of cases treated with sulphapyridine 
(N & B 693) the discharge ceased in twenty -four 
hours and the risk of complication is therefore al- 
most nil. Relapses are to a great extent due to 
drug resistance where patients have previously been 
treated by inadequate doses. McLean, Rogers, and 
33 
Fleming have proved that pneumococci in mice treat- 
ed with sulphapyridine (M & B 693) established a 
tolerance to the drug, and they stated that the ini- 
tial dose should be large. Laboratory experiments 
34 
by Westphal and Carpenter say that gonococci have 
been/ 
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been successfully sub -cultured on media containing 
increasing strengths of a sulphonamide compound and 
have shown that drug resistance can be acquired 
"in vitro." In my series 202 of relapses after sul- 
phanilamide and 1O after sulphapyridine (M & B 693) 
were mostly due to drug resistance. Cokkinis and 
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McElligott reported that 20;c: of their 1,268 males 
and 210 females relapsed, and other letters in sub- 
sequent numbers of the B.M.J. agreed with them. In 
their cases there were 154 which did not have a 
G.C.1'. smear and these may have been non -venereal 
which relapse more easily with sulphapyridine (M & B 
693). I have found in my series that 3 grammes of 
sulphapyridine daily for 5 days, 15 grammes in all, 
in early uncomplicated cases clears up the discharge, 
and if the patients attend regularly for five suc- 
cessive weeks for tests for cure and observation, 
they can be discharged as cured. I get them to irri- 
gate at the start, though I doubt if this is really 
necessary. The psychological value of treating the 
disease, apart from a box of tablets, is I am sure 
important to the patient. This may seem a short 
time to some research workers but my feeling is that 
if the drug is effective in twenty -four hours and 
cures in one week, surely five weeks of tests is 
long enough if a case is going to relapse. In this, 
however, I differ from other venereologists. 
Batchelor/ 
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Batchelor, Lees and Thompson advise three months 
before discharging as cured. After the same dosage; 
their figures for cures were 54 with sulphanila- 
mide and 47' with suiphapyridine (M & B 693), which¡ 
compare very much with mine of 43% and 50%. With 
their longer observation period my defaulters are 
¡ 
less, 30, both, while they have 46% and 53 %. 
But if we add my apparent cures, 26% and 20 %, this 
brings them more equal, 56% and 50 ¡ . 
I note the Army Authorities have lately extend- 
ed their period of observation from one month to 
three months for gonorrhoea and the R.A.F. six 
months, so it would seem that they have been hav- 
ing relapses with suiphapyridine (M & B 693). 
Looking at days under treatment my figures with 
irrigation average 75 days, with sulphanilamide 55 
days, and with suiphapyridine (M & B 693) 52 days 
for 60 cases. In my latest series, however, the 
latter reads 41 days with suiphapyridine for 25 
cases. MacKinnon found with irrigation that he 
cured his patients in 48 days, with suiphapyridine 
(TT & B 693) 21 days, but his standard of cure is 
not stated. Somerville used much smaller doses. 
He used 1 tablet 4 times a day (2 gms) and obtained 
an early cure in 90% of cases, but he gives no in- 
dication of late relapses and tests for cure and it 
would be of interest to know his results. He 
mentions/ 
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mentions a point I also found in my series, namely, 
that it did not seem to natter how long a time had 
elapsed since the onset of the disease before first 
treating the patient with sulphapyridine (M & B 
693). The smear becomes G.C. -. just as quickly. 
I think I have established that an early un- 
complicated case of tale gonorrhoea treated ade- 
quately with sulphapyridine (M & B 693) who attends 
regularly should be capable of being discharged 
cured in 35 days 2( The danger with the sulphanil- 
amides I am sure is that owing to their almost 
dramatic effects the patient treated by his own 
practitioner with a box of tablets without adequate 
instruction and period of observation and tests for 
cure may quite easily relapse and then bring dis- 
repute on a treatment that in capable hands is a 
very distinct advance in medical history. 
Finally, I must thank A.C.B. McMurtrie, M.D., 
F.R.C.S.E. who allowed me to do this work at his 
clinic at the Cumberland Infirmary. 
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C O N C L U S I O N S 
Sulphanilamide, sulphapyridine and sulphathi- 
azole are exceedingly potent drugs in the treatment 
of gonorrhoea, and there is not much to choose be- 
tween them in the matter of cure. 
Toxic effects were frequent but were never 
severe. They were much more marked with sulpha- 
pyridine, especially in the female, but we seem to 
have found the solution to this in sulphathiazole. 
Al]. cases need observation and strict instructions 
how to take the drug in order to secure the maximum 
benefit. It is not enough to give a box of tab- 
lets, promise cure, and neglect tests for cure. 
Relapses occurred in the majority of cases after 
inadequate doses given by the patientst private 
practitioners, and no good results can be obtained 
by using the suiphanilamides again in adequate 
doses until the patient loses his drug resistance 
which takes about fourteen days. Sulphapyridine 
should in an uncomplicated case dry up discharge 
in twenty -four hours. If it fails to do so, sus- 
pect complication. 
The Gonococcal Complement Fixation test in the 
male is of importance as a test in doubtful clini- 
cal cases without a positive smear, and in the fe- 
male as a test for cure. Early cases under treat- 
ment with sulphapyridine (M & B 693) however, never 
become positive. 
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